International Review of Neurobiology

1st Edition, Volume 57 - December 18, 2003
Editors: Ronald J. Bradley, R. Adron Harris, Peter Jenner
Language: English
Paperback ISBN:
9 7 8 - 0 - 1 2 - 3 9 1 8 1 7 - 8
Hardback ISBN:
9 7 8 - 0 - 1 2 - 3 6 6 8 5 8 - 5
eBook ISBN:
9 7 8 - 0 - 0 8 - 0 4 9 5 4 9 - 1

International Review of Neurobiology is a well-respected series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an intern… Read more

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code needed.

Institutional subscription on ScienceDirect

Request a sales quote

International Review of Neurobiology is a well-respected series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research. This volume is a cumulative subject index of volumes 1-25.

Ronald J. Bradley

Affiliations and expertise

Louisiana State University Medical Center, School of Medicine, Baton Rouge, U.S.A.

R. Adron Harris

Affiliations and expertise

University of Texas, USA

Peter Jenner

Professor Peter Jenner is a specialist in preclinical aspects of neurodegenerative diseases, notably Parkinson’s disease. He has spent the major part of his career at King’s College London where he was Head of Pharmacology for 14 years before returning to his research roots and subsequently becoming Emeritus Professor of Pharmacology. Peter has expertise in drug metabolism and pharmacokinetics but neuropharmacology based on functional models of neurodegenerative diseases has formed the major focus of his work. Peter holds a BPharm, PhD and DSc degree from the University of London. He has published well over 1000 articles with more than 700 peer reviewed papers. He is a Fellow of the Royal Pharmaceutical Society, the British Pharmacological Society, the Royal Society of Medicine and of King’s College London. Peter was recently honoured with a Doctor Honoris Causa degree from Carol Davila University of Medicine and Pharmacy, Bucharest and made an Honorary Fellow of The British Pharmacological Society for his contribution to research in to movement disorders. Peter has worked closely with the pharmaceutical industry for many years and acts as an adviser and consultant to both major pharma and biotech companies. He has a wide knowledge of the drug discovery and drug development process and has been involved from molecule synthesis through to drug registration for use in man. Peter was the Founder, Director and Chief Scientific Officer of Proximagen, a biotech focussed on the treatment and cure of neurodegenerative diseases that was listed on AIMs and subsequently purchased by a US based healthcare company. He is a regular speaker at international meetings and also takes time to speak at Parkinson’s disease patient-carer groups across the UK.

Affiliations and expertise

Emeritus Professor of Pharmacology, Institute of Pharmaceutical Sciences, King’s College London, London, UK

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

International Review of Neurobiology

Purchase options

Save 50% on book bundles

Institutional subscription on ScienceDirect

Ronald J. Bradley

R. Adron Harris

Peter Jenner